Targeting SF3B1 in High-Risk B-Cell Acute Lymphoblastic Leukemia

被引：0
|
作者：
Murakami, Yuki [1 ,2 ]
Konishi, Hiroaki [2 ]
Tepper, Cliff [1 ,3 ]
McPherson, John [1 ,3 ]
Satake, Noriko [1 ,2 ]
机构：
[1] Univ Calif Davis, Ctr Comprehens Canc, Davis, CA USA
[2] Univ Calif Davis, Dept Pediat, Davis, CA USA
[3] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-188098
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Targeting the spliceosome in high-risk B-cell acute lymphoblastic leukemia
    Murakami, Yuki
    Konishi, Hiroaki
    Tepper, Clifford
    McPherson, John
    Satake, Noriko
    CANCER RESEARCH, 2024, 84 (06)
  • [2] Targeting osteoclasts for treatment of high-risk B-cell acute lymphoblastic leukemia
    Kotecha, Rishi S.
    Trinder, Sarah M.
    Hughes, Anastasia M.
    Mullin, Benjamin H.
    Rashid, Sarah
    Yuan, Jinbo
    Xu, Jiake
    Duncan, Owen
    Skut, Patrycja
    Chua, Grace-Alyssa
    Singh, Sajla
    Oommen, Joyce
    Lock, Richard B.
    Kees, Ursula R.
    Malinge, Sebastien
    Kuek, Vincent
    Cheung, Laurence C.
    BLOOD CANCER JOURNAL, 2025, 15 (01):
  • [3] Targeting Bone Marrow Microenvironment for Treatment of High-Risk B-Cell Acute Lymphoblastic Leukemia
    Cheung, Laurence C.
    Trinder, Sarah
    Hughes, Anastasia
    Mullin, Benjamin
    Rashid, Sarah
    Yuan, Jinbo
    Xu, Jiake
    Duncan, Owen
    Lock, Richard B.
    Malinge, Sebastien
    Kuek, Vincent
    Kotecha, Rishi Sury
    BLOOD, 2023, 142
  • [4] TARGETING BONE MARROW MICROENVIRONMENT FOR TREATMENT OF HIGH-RISK B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Cheung, Laurence
    Lock, Richard
    Kuek, Vincent
    Kotecha, Rishi
    EXPERIMENTAL HEMATOLOGY, 2024, 137
  • [5] TARGETING BONE MARROW MICROENVIRONMENT FOR TREATMENT OF HIGH-RISK B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Cheung, Laurence
    Lock, Richard
    Kuek, Vincent
    Kotecha, Rishi
    EXPERIMENTAL HEMATOLOGY, 2024, 137
  • [6] Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia
    Ge, Zheng
    Song, Chunhua
    Ding, Yali
    Tan, Bi-Hua
    Desai, Dhimant
    Sharma, Arati
    Gowda, Raghavendra
    Yue, Feng
    Huang, Suming
    Spiegelman, Vladimir
    Payne, Jonathon L.
    Reeves, Mark E.
    Iyer, Soumya
    Dhanyamraju, Pavan Kumar
    Imamura, Yuka
    Bogush, Daniel
    Bamme, Yevgeniya
    Yang, Yiping
    Soliman, Mario
    Kane, Shriya
    Dovat, Elanora
    Schramm, Joseph
    Hu, Tommy
    McGrath, Mary
    Chroneos, Zissis C.
    Payne, Kimberly J.
    Gowda, Chandrika
    Dovat, Sinisa
    LEUKEMIA, 2021, 35 (05) : 1267 - 1278
  • [7] Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia
    Zheng Ge
    Chunhua Song
    Yali Ding
    Bi-Hua Tan
    Dhimant Desai
    Arati Sharma
    Raghavendra Gowda
    Feng Yue
    Suming Huang
    Vladimir Spiegelman
    Jonathon L. Payne
    Mark E. Reeves
    Soumya Iyer
    Pavan Kumar Dhanyamraju
    Yuka Imamura
    Daniel Bogush
    Yevgeniya Bamme
    Yiping Yang
    Mario Soliman
    Shriya Kane
    Elanora Dovat
    Joseph Schramm
    Tommy Hu
    Mary McGrath
    Zissis C. Chroneos
    Kimberly J. Payne
    Chandrika Gowda
    Sinisa Dovat
    Leukemia, 2021, 35 : 1267 - 1278
  • [8] Personalized therapy in pediatric high-risk B-cell acute lymphoblastic leukemia
    Karol, Seth E.
    Pui, Ching-Hon
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
  • [9] Chromatin accessibility landscape of pediatric high-risk B-cell acute lymphoblastic leukemia
    Wang, Han
    Sun, Huiying
    Liang, Bilin
    Zhang, Fang
    Yang, Fan
    Cui, Bowen
    Ding, Lixia
    Wang, Ronghua
    Tang, Yanjing
    Rao, Jianan
    Hu, Wenting
    Zhao, Shuang
    Wu, Wenyan
    Li, Benshang
    Tang, Jingyan
    Shen, Shuhong
    Liu, Yu
    CANCER RESEARCH, 2022, 82 (12)
  • [10] Blinatumomab for Treatment of Children With High-risk Relapsed B-Cell Acute Lymphoblastic Leukemia
    Shukla, Neerav
    Sulis, Maria Luisa
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (09): : 830 - 832
12345